BioSpace News Archive

Maravai LifeSciences Holdings, Inc., a global provider of life science reagents and services to researchers and biotech innovators, announced the pricing of a public offering of 20,000,000 shares of Maravai’s Class A common stock by certain selling stockholders that was previously announced, at a public offering price of $50.00 per share.

Immunocore Holdings plc, a late-stage biotechnology company pioneering the development of a novel class of T cell receptor bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, announced that management will present at the following investor conferences in September.

Rocket Pharmaceuticals, Inc. today announces that previously disclosed data from the ongoing Phase 1 trial of RP-A501 in Danon Disease will be presented in a late-breaking oral presentation at the upcoming Heart Failure Society of America (HFSA) Annual Scientific Meeting 2021.

CytoSorbents Corporation announces the filing of an Investigational Device Exemption (IDE) application to gain FDA approval to conduct the clinical study, “Safe and Timely Antithrombotic Removal – Direct Oral Anticoagulants (STAR-D),”

Syros Pharmaceuticals today announced the appointment of Deborah Dunsire, M.D., to the Company’s Board of Directors.

Elicio Therapeutics today announced that it presented preclinical data on its Amphiphile (AMP) platform in combination with TCR-T therapy in solid tumors at the 6th Annual CAR-TCR summit, that was held virtually from August 30 – September 2, 2021.

Portage Biotech Inc. today announced that as part of its commitment to investor outreach, management will be participating in the following investor conferences in September 2021. H.C. Wainwright 23rd Annual Global Investor Conference Date: September 13, 2021

Catalyst Pharmaceuticals, Inc. announced that Patrick J. McEnany, Catalyst’s Chief Executive Officer and Steven Miller, Ph.D., Chief Scientific Officer /COO, will participate in two upcoming investor conferences:.

Better Therapeutics, Inc. has been invited to present at the Lake Street’s 5th Annual Best Ideas Growth (BIG5) Conference , which is being held virtually on September 14-15, 2021.

Spinal Elements today announced it has reached the milestone of completing 100 Sapphire X procedures after only a few weeks of commercialization.